Federal Register / Vol. 69, No. 224 / Monday, November 22, 2004 / Notices 67963

by renewal to the Drug Enforcement 

Administration (DEA) for registration as 

a bulk manufacturer of the basic classes 

of controlled substances listed:

Drug Schedule 

2, 5–Dimethoxyamphetamine 

(7396).

I 

Amphetamine (1100) .................... II 

Phenylacetone (8501) .................. II 

The company plans to manufacture 

phenylacetone to be used in the 

manufacture of the amphetamine. The 

bulk 2, 5–dimethoxyamphetamine will 

be used for conversion into noncontrolled substances. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such substance 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such comments or objections 

may be addressed, in quintuplicate, to 

the Deputy Assistant Administrator, 

Office of Diversion Control, Drug 

Enforcement Administration, United 

States Department of Justice, 

Washington, DC 20537, Attention: DEA 

Federal Register Representative, Office 

of Liaison and Policy (ODLR) and must 

be filed no later than January 21, 2005.

Dated: November 8, 2004. 

William J. Walker, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration.

[FR Doc. 04–25767 Filed 11–19–04; 8:45 am] 

BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in Schedule I or II and prior 

to issuing a registration under 21 U.S.C. 

952(a)(2)(B) authorizing the importation 

of such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with 21 CFR 

1301.34(a), this is notice that on August 

20, 2004, ISP Freetown Fine Chemicals, 

238 South Main Street, Assonet, 

Massachusetts 02702, made application 

by renewal to the Drug Enforcement 

Administration (DEA) for registration as 

an importer of Phenylacetone (8501), a 

basic class of controlled substance listed 

in Schedule II. 

The company plans to import 

Phenylacetone to manufacture 

amphetamine. 

Any manufacturer who is presently, 

or is applying to be, registered with DEA 

to manufacture such basic class of 

controlled substance may file comments 

or objections to the issuance of the 

proposed registration and may, at the 

same time, file a written request for a 

hearing on such application pursuant to 

21 CFR 1301.43 and in such form as 

prescribed by 21 CFR 1316.47. 

Any such comments or objections or 

requests for hearing may be addressed, 

in quintuplicate, to the Deputy Assistant 

Administrator, Office of Diversion 

Control, Drug Enforcement 

Administration, United States 

Department of Justice, Washington, DC 

20537, Attention: DEA Federal Register 

Representative, Office of Liaison and 

Policy (ODLR) and must be filed no later 

than December 22, 2004. 

This procedure is to be conducted 

simultaneously with, and independent, 

of the procedures described in 21 CFR 

1301.34(b), (c), (d), (e) and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745–46), all applicants for 

registration to import a basic class of 

any controlled substances in Schedule I 

or II are and will continue to be required 

to demonstrate to the Deputy Assistant 

Administrator, Office of Diversion 

Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a), 21 U.S.C. 823(a), and 21 

CFR 1301.34(b), (c), (d), (e) and (f) are 

satisfied.

Dated: November 8, 2004. 

William J. Walker, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration.

[FR Doc. 04–25768 Filed 11–19–04; 8:45 am] 

BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to Section 1301.33(a) of Title 

21 of the Code of Federal Regulations 

(CFR), this is notice that on September 

28, 2004, Orasure Technologies, Inc., 

Lehigh University, Seeley G. MuddBuilding 6, Bethlehem, Pennsylvania 

18015, made application by renewal to 

the Drug Enforcement Administration 

(DEA) for registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed:

Drug Schedule 

Alphamethadol (9605) .................. I 

Benzoylecgonine (9180) ............... II 

Morphine (9300) ........................... II 

The company plans to manufacture 

the listed controlled substances in bulk 

to manufacture other controlled 

substances. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such substances 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such comments or objections 

may be addressed, in quintuplicate, to 

the Deputy Assistant Administrator, 

Office of Diversion Control, Drug 

Enforcement Administration, United 

States Department of Justice, 

Washington, DC 20537, Attention: DEA 

Federal Register Representative, Office 

of Liaison and Policy (ODLR) and must 

be filed no later than January 21, 2005.

Dated: November 8, 2004. 

William J. Walker, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration.

[FR Doc. 04–25769 Filed 11–19–04; 8:45 am] 

BILLING CODE 4410–09–P

DEPARTMENT OF LABOR

Employment and Training 

Administration 

Trade Adjustment Assistance 

Program: Training and Employment 

Guidance Letter Interpreting Federal 

Law; Correction

AGENCY: Employment and Training 

Administration, Labor.

ACTION: Correction.

SUMMARY: In notice document 04–22919 

beginning on page 60903 in the issue of 

Wednesday, October 13, 2004, make the 

following correction: 

On page 60903, the heading to the 

document was omitted and should be 

added to read: Employment and 

Training Advisory System, U.S. 

Department of Labor, Washington, DC 

20210. 

Classification: TAA. 

Correspondence Symbol: ONR. 

Date: November 6, 2003.